The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
The Kidney: Physiology and Pathophysiology
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-544_3 · Cited by 1,673
Identification of a Gene That Causes Primary Open Angle Glaucoma
Stone, E. M., Fingert, J. H., Alward, W. L. M., Nguyen, T. D., Polansky, J. R., Sunden, S. L. F., Nishimura, D., Clark, A. F., Nystuen, A., Nichols, B. E., et al. (1997) · Science · doi:10.1126/science.275.5300.668 · Cited by 1,433
Polymyalgia Rheumatica and Giant-Cell Arteritis
Salvarani, C., Cantini, F., Boiardi, L., & Hunder, G. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011913 · Cited by 1,352
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
Self-citationRecommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 836
The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis
Kirwan, J. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330302 · Cited by 817
Self-citationPRIMER ON THE RHEUMATIC DISEASES: PART I
(1959) · Journal of the American Medical Association · doi:10.1001/jama.1959.73010270003011 · Cited by 804
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Yale, S. H., & Limper, A. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.1.5 · Cited by 644
Human Leptin Levels Are Pulsatile and Inversely Related to Pituitary–Ardenal Function
Licinio, J., Mantzoros, C., Negrão, A. B., Cizza, G., Wong, M.-L., Bongiorno, P. B., Chrousos, G. P., Karp, B., Allen, C., Flier, J. S., et al. (1997) · Nature Medicine · doi:10.1038/nm0597-575 · Cited by 632
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez-Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 624
Landewé, R. B. M., Boers, M., Verhoeven, A. C., Westhovens, R., van de Laar, M. A. F. J., Markusse, H. M., van Denderen, J. C., Westedt, M. L., Peeters, A. J., Dijkmans, B. A. C., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10083 · Cited by 612
Self-citationCorticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs
Piper, J. M., Ray, W. A., Daugherty, J. R., & Griffin, M. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-735 · Cited by 608
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
(1965) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb71746.x · Cited by 585
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. G., Rairie, J. E., Tracy, R. P., & Kuller, L. H. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<51::aid-anr7>3.0.co;2-d · Cited by 559
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.718 · Cited by 544
Self-citationSaag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Self-citationSteroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528
Damage in systemic lupus erythematosus and its association with corticosteroids
Zonana-Nacach, A., Barr, S. G., Magder, L. S., & Petri, M. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1801::aid-anr16>3.0.co;2-o · Cited by 495
van Everdingen, A. A., Jacobs, J. W. G., Siewertsz van Reesema, D. R., & Bijlsma, J. W. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00006 · Cited by 489
Self-citationAssociation of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease
Messer, J., Reitman, D., Sacks, H. S., Smith, H., & Chalmers, T. C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090105 · Cited by 422
Lambillotte, C., Gilon, P., & Henquin, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119175 · Cited by 419
Effects of glucocorticoids on energy metabolism and food intake in humans
Tataranni, P. A., Larson, D. E., Snitker, S., Young, J. B., Flatt, J. P., & Ravussin, E. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.2.e317 · Cited by 414
Laan, R. F. J. M., van Riel, P. L. C. M., van de Putte, L. B. A., van Erning, L. J. T. O., van't Hof, M. A., & Lemmens, J. A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00001 · Cited by 411
Wållberg‐Jonsson, S., Johansson, H., Ohman, M. L., & Rantapää‐Dahlqvist, S. (1999) · PubMed · Cited by 409
Reduction of Serum Testosterone Levels During Chronic Glucocorticoid Therapy
MacADAMS, M. R., WHITE, R. H., & CHIPPS, B. E. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-5-648 · Cited by 391
Primer on the Rheumatic Diseases
Ehrlich, G. E. (2008) · JAMA · doi:10.1001/jama.299.10.1195-a · Cited by 356
Nonassociation of Adrenocorticosteroid Therapy and Peptic Ulcer
Conn, H. O., & Blitzer, B. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940905 · Cited by 353
Acute Suppression of Circulating Testosterone Levels by Cortisol in Men*
CUMMING, D. C., QUIGLEY, M. E., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-671 · Cited by 333
Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.
Delaunay, F., Khan, A., Cintra, A., Davani, B., Ling, Z. C., Andersson, A., Ostenson, C. G., Gustafsson, J., Efendic, S., & Okret, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119743 · Cited by 333
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
Eastell, R., Reid, D. M., Compston, J., Cooper, C., Fogelman, I., Francis, R. M., Hosking, D. J., Purdie, D. W., Ralston, S. H., Reeve, J., et al. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00408.x · Cited by 315
Glucocorticoids and the risk for initiation of hypoglycemic therapy
Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314
Corticosteroids and peptic ulcer: meta‐analysis of adverse events during steroid therapy
CONN, H. O., & POYNARD, T. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00855.x · Cited by 312
Marcocci, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3562 · Cited by 309
Wassenberg, S., Rau, R., Steinfeld, P., Zeidler, H., & Low‐Dose Prednisolone Therapy Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21421 · Cited by 308
Self-citationAlternate-Day Prednisone: Leukocyte Kinetics and Susceptibility to Infections
Dale, D. C., Fauci, A. S., & Wolff, S. M. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411282912203 · Cited by 294
Boers, M., Nurmohamed, M. T., Doelman, C. J. A., Lard, L. R., Verhoeven, A. C., Voskuyl, A. E., Huizinga, T. W. J., van de Stadt, R. J., Dijkmans, B. A. C., & van der Linden, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.842 · Cited by 283
Self-citationHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
Adverse effects of corticosteroids on the cardiovascular system.
De, S., & Armstrong, P. W. (2000) · PubMed · Cited by 264
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau, B., Coutant-Perronne, V., Huong, D. U. L. T., Guillevin, L., Magadur, G., Bandt, M. D., Dellion, S., Rossert, J., Rostoker, G., & Pietté, J. C. (1994) · PubMed · Cited by 254
R�egsegger, P., Medici, T. C., & Anliker, M. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542348 · Cited by 245
García Rodríguez, L. A., & Hernández-Díaz, S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar146 · Cited by 236
PETRI, M., SPENCE, D., BONE, L. R., & HOCHBERG, M. C. (1992) · Medicine · doi:10.1097/00005792-199209000-00004 · Cited by 234
Corticosteroids and Glaucoma Risk
Tripathi, R. C., Parapuram, S. K., Tripathi, B. J., Zhong, Y., & Chalam, K. (1999) · Drugs & Aging · doi:10.2165/00002512-199915060-00004 · Cited by 228
Fatal Infections in Systemic Lupus Erythematosus: The Role of Opportunistic Organisms
HELLMANN, D. B., PETRI, M., & WHITING-OʼKEEFE, Q. (1987) · Medicine · doi:10.1097/00005792-198709000-00002 · Cited by 228
Rifampicin reduces effectiveness and bioavailability of prednisolone.
McAllister, W. A., Thompson, P. J., Al-Habet, S. M., & Rogers, H. J. (1983) · BMJ · doi:10.1136/bmj.286.6369.923 · Cited by 227
Naber, D., Sand, P., & Heigl, B. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00031-3 · Cited by 223
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
CHANGES IN CORTISOL METABOLISM FOLLOWING RIFAMPICIN THERAPY
Edwards, O., Galley, J. M., Courtenay-Evans, R. J., Hunter, J., & Tait, A. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91876-5 · Cited by 209
Hickling, P., Jacoby, R. K., & Kirwan, J. R. (1998) · Rheumatology · doi:10.1093/rheumatology/37.9.930 · Cited by 201
Self-citationBone loss in adults receiving alternate day glucocorticoid therapy
Gluck, O. S., Murphy, W. A., Hahn, T. J., & Hahn, B. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240705 · Cited by 197
Connell, J. M. C., Whitworth, J. A., Davies, D. L., Lever, A. F., Richards, A. M., & Fraser, R. (1987) · Journal of Hypertension · doi:10.1097/00004872-198708000-00007 · Cited by 188
Determinants of Vertebral Mineral Density in Patients Receiving Long-term Glucocorticoid Therapy
Reid, I. R. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.12.2545 · Cited by 184
Adverse Effects of Phenobarbital on Corticosteroid Metabolism in Patients with Bronchial Asthma
Brooks, S. M., Werk, E. E., Ackerman, S. J., Sullivan, I., & Thrasher, K. (1972) · New England Journal of Medicine · doi:10.1056/nejm197205252862103 · Cited by 179
Mechanisms of glucocorticoid–induced hypertension
Whitworth, J. A. (1987) · Kidney International · doi:10.1038/ki.1987.131 · Cited by 174
Corticosteroid-Induced Adverse Psychiatric Effects: Incidence, Diagnosis and Management
Patten, S. B., & Neutel, C. I. (2000) · Drug Safety · doi:10.2165/00002018-200022020-00004 · Cited by 172
Changes in Visual Acuity in a Population Over a 15-year Period: The Beaver Dam Eye Study
Klein, R., Klein, B. E. K., Lee, K. E., Cruickshanks, K. J., & Gangnon, R. E. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.06.015 · Cited by 172
Klein, R., Klein, B. E. K., Lee, K. E., Cruickshanks, K. J., & Chappell, R. J. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00769-2 · Cited by 166
Capell, H. A., Madhok, R., Hunter, J. A., Porter, D., Morrison, E., Larkin, J., Thomson, E. A., Hampson, R., & Poon, F. W. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014050 · Cited by 160
Self-citationAcute Pancreatic Lesions in Patients Treated with ACTH and Adrenal Corticoids
Carone, F. A., & Liebow, A. A. (1957) · New England Journal of Medicine · doi:10.1056/nejm195710102571502 · Cited by 158
Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma
Covar, R. A., Leung, D. Y. M., McCormick, D., Steelman, J., Zeitler, P. S., & Spahn, J. D. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.109830 · Cited by 147
Statins and the Acute-Phase Response
Munford, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442609 · Cited by 142
Corticosteroids and Infectious Diseases
Dale, D. C., & Petersdorf, R. G. (1973) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32228-3 · Cited by 142
Vertebral Fracture Risk With Long-term Corticosteroid Therapy
Naganathan, V., Jones, G., Nash, P. T., Nicholson, G. C., Eisman, J. A., & Sambrook, P. N. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.19.2917 · Cited by 141
Reilly, J. J., Brougham, M. F. H., Montgomery, C., Richardson, F., Kelly, A., & Gibson, B. E. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7764 · Cited by 141
The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume
Whitworth, J. A., Gordon, D., Andrews, J., & Scoggins, B. A. (1989) · Journal of Hypertension · doi:10.1097/00004872-198907000-00005 · Cited by 126
Smyllie, H. C., & Connolly, C. K. (1968) · Thorax · doi:10.1136/thx.23.6.571 · Cited by 126
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy
Fost, D. A., Leung, D. Y. M., Martin, R. J., Brown, E. E., Szefler, S. J., & Spahn, J. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70175-2 · Cited by 125
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients
Becker, D. M., CHAMBERLAIN, B., Swank, R. T., Hegewald, M. G., GIRARDET, R., BAUGHMAN, K., KWITEROVICH, P., PEARSON, T., ETTINGER, W., & RENLUND, D. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80234-1 · Cited by 121
Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology
Cattran, D. C., STEINER, G., WILSON, D. R., & FENTON, S. S. A. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-4-554 · Cited by 117
The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis
Caldwell, J. R., & Fürst, D. E. (1991) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(91)90051-z · Cited by 115
Lipid profiles in patients with systemic lupus erythematosus.
Leong, K. H., Koh, E. T., Ph, F., & Boey, M. L. (1994) · PubMed · Cited by 113
Tayek, J. A., & Katz, J. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.3.e476 · Cited by 111
Kyriazopoulou, V. E., PARPAROUSI, O., & Vagenakis, A. G. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1204 · Cited by 108
MacGregor, A. J., Dhillon, V. B., Binder, A. I., Forte, C. A., Knight, B. C., Betteridge, D. J., & Isenberg, D. A. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.2.152 · Cited by 105
DIABETES MANAGEMENT IN SPECIAL SITUATIONS
Hirsch, I. B., & Paauw, D. S. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70271-1 · Cited by 101
Effect of Corticosteroids on Blood Salicylate Concentration
Klinenberg, J. R., & Miller, F. (1965) · JAMA · doi:10.1001/jama.1965.03090190023006 · Cited by 96
de Nijs, R. N. J. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.12.1375 · Cited by 92
Asai, K., FUNAKI, C., Hayashi, T., Yamada, K., Naito, M., Kuzuya, M., Yoshida, F., Yoshimine, N., & Kuzuya, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.892 · Cited by 89
Verhoeven, A. C., & Boers, M. (1997) · PubMed · Cited by 88
Self-citationCorticosteroid-Induced Bone Loss: Prevention and Management
Picado, C., & Luengo, M. (1996) · Drug Safety · doi:10.2165/00002018-199615050-00005 · Cited by 86
Latham, R. D., Mulrow, J. P., Virmani, R., Robinowitz, M., & Moody, J. M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90626-1 · Cited by 85
Hyperlipidaemia in Asthmatic Patients Receiving Long-term Steroid Therapy
El-Shaboury, A. H., & Hayes, T. M. (1973) · BMJ · doi:10.1136/bmj.2.5858.85 · Cited by 81
DRUG SELECTION AND THE MANAGEMENT OF CORTICOSTEROID-RELATED DIABETES MELLITUS
Hoogwerf, B. J., & Danese, R. D. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70083-1 · Cited by 80
Impact of ketoconazole on the metabolism of prednisolone
Zürcher, R. M., Frey, B. M., & Frey, F. J. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.42 · Cited by 79
Effectiveness of prednisolone during phenytoin therapy
Petereit, L. B., & Meikle, A. W. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977226912 · Cited by 68
Does Long-Term Low-Dose Corticosteroid Therapy Cause Hypertension?
Jackson, S. H. D., Beevers, D. G., & Myers, K. (1981) · Clinical Science · doi:10.1042/cs061381s · Cited by 64
Stjernholm, M. R., & Katz, F. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-887 · Cited by 63
Posterior subcapsular cataracts in steroid-requiring asthmatic children
Rooklin, A. R., Lampert, S. I., Jaeger, E. A., McGeady, S. J., & Mansmann, H. C. (1979) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(79)90210-0 · Cited by 61
Sambrook, P. N., & Jones, G. (1995) · Rheumatology · doi:10.1093/rheumatology/34.1.8 · Cited by 61
Mineralo- and glucocorticoid effects on renal excretion of electrolytes
Campen, T. J., Vaughn, D. A., & Fanestil, D. D. (1983) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00663903 · Cited by 59
Tornatore, K. M., Biocevich, D. M., Reed, K. A., Tousley, K., Singh, J. P., & Venuto, R. C. (1995) · Transplantation · doi:10.1097/00007890-199503150-00016 · Cited by 58
for the LDPT-Study Group, Rau, R., Wassenberg, S., & Zeidler, H. K. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070026 · Cited by 57
Self-citationDose- and time-related effect of troleandomycin on methylprednisolone elimination
Szefler, S. J., Brenner, M., Jusko, W. J., et al. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.143 · Cited by 57
Prednisolone Disposition and Protein Binding in Oral Contraceptive Users*
Boekenoogen, S. J., Szefler, S. J., & Jusko, W. J. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-4-702 · Cited by 56
Inhibition of methylprednisolone elimination in the presence of erythromycin therapy
LAFORCE, C., Szefler, S. J., MILLER, M., et al. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90049-0 · Cited by 56
Effect of alternate-day prednisone on plasma lipids in renal transplant recipients
Curtis, J. J., Galla, J. H., Woodford, S. Y., Lucas, B. A., & Luke, R. G. (1982) · Kidney International · doi:10.1038/ki.1982.130 · Cited by 54
Lin, C. W., Nakane, M., Stashko, M., Falls, D. H., Kuk, J. E., Miller, L. N., Huang, R., Tyree, C. M., Miner, J. N., Rosen, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.297 · Cited by 53
Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy
Szefler, S. J., Ellis, E. F., Brenner, M., Rose, J. Q., Spector, S. L., Yurchak, A. M., Andrews, F., & Jusko, W. J. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90121-x · Cited by 52
Wolfe, F., & Hawley, D. J. (2000) · PubMed · Cited by 51
Cortisol, 11β-hydroxysteroid dehydrogenase type 1 and central obesity
Stewart, P. M., & Tomlinson, J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00566-0 · Cited by 50
Danneskiold‐Samsøe, B., & Grimby, G. (1986) · Clinical Science · doi:10.1042/cs0710693 · Cited by 50
Exogenous corticosteroid effects on mood and cognition: case presentations.
Reckart, M. D., & Eisendrath, S. J. (1990) · PubMed · Cited by 49
The Effect of Dexamethasone on Renal Electrolyte Excretion in the Adrenalectomized Rat
BIA, M. J., Tyler, K., & DeFronzo, R. A. (1982) · Endocrinology · doi:10.1210/endo-111-3-882 · Cited by 47
Control of arterial pressure and renal function during glucocorticoid excess in dogs.
Hall, J. E., Morse, C. L., Smith, M. J., Young, D. B., & Guyton, A. C. (1980) · Hypertension · doi:10.1161/01.hyp.2.2.139 · Cited by 45
Bruno, A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.4.679 · Cited by 45
Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids.
Lems, W. F., Jahangier, Z. N., Jacobs, J. W. G., & Bijlsma, J. W. J. (1995) · PubMed · Cited by 44
Self-citationAdverse effects of corticosteroids.
Bialas, M. C., & Routledge, P. (1998) · PubMed · Cited by 44
Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.
Frey, F. J., & Frey, B. M. (1983) · PubMed · Cited by 43
Impairment of Prednisolone Disposition in Women Taking Oral Contraceptives or Conjugated Estrogens*
Gustavson, L. E., Legler, U. F., & Benet, L. Z. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-234 · Cited by 43
Aseptic bone necrosis in patients on glucocorticoid replacement therapy.
Vreden, S. G., Hermus, A. R. M. M., van Liessum, P. A., et al. (1991) · PubMed · Cited by 40
Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone
Yamashita, S. K., Ludwig, E. A., Middleton, E., & Jusko, W. J. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.66 · Cited by 37
Management of corticosteroid-induced osteoporosis
Yeap, S. S. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.10.1088 · Cited by 37
Adverse effects of corticosteroids: II. systemic
Davis, G. F. (1986) · Clinics in Dermatology · doi:10.1016/0738-081x(86)90020-9 · Cited by 36
Kautzky-Willer, A., Thomaseth, K., Clodi, M., Ludvik, B., Waldhäusl, W., Prager, R., & Pacini, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90224-3 · Cited by 35
Sambrook, P. N., & Lane, N. E. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0157 · Cited by 35
Barbosa, J. J., Menth, L., Eaton, J. W., Sutherland, D. E. R., Freier, E. F., & Najarian, J. S. (1981) · Diabetes Care · doi:10.2337/diacare.4.2.269 · Cited by 34
Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone
Frey, B. M., Schaad, H. J., & Frey, F. J. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542149 · Cited by 32
Advances in glucocorticoid therapy.
Baxter, J. D. (2000) · PubMed · Cited by 32
Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection.
Black, D. M., & Filak, A. T. (1989) · PubMed · Cited by 31
Rifampin-Induced Nonresponsiveness of Giant Cell Arteritis to Prednisone Treatment
Carrie, F. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1521 · Cited by 30
Effects of dexamethasone on hepatic glucose production and fructose metabolism in healthy humans
Tounian, P., Schneiter, P., Henry, S., Delarue, J., & Tappy, L. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e315 · Cited by 29
Oestrogens, the menopause and the adrenopause.
Nordin, B. E. C., Crilly, R. G., Marshall, D. H., & Barkworth, S. A. (1981) · PubMed · Cited by 29
Dexamethasone Hypertension in Rats
Okuno, T., Suzuki, H., & Saruta, T. (1981) · Clinical and Experimental Hypertension · doi:10.3109/10641968109033722 · Cited by 28
Bruno, A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040061011 · Cited by 27
Kaufman, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300406 · Cited by 23
Hampson, G., Bhargava, N., Cheung, J., Vaja, S., Seed, P. T., & Fogelman, I. (2002) · Metabolism · doi:10.1053/meta.2002.35583 · Cited by 22
Frey, B. M., & Frey, F. J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00695.x · Cited by 21
Principles of Corticosteroid Therapy
Lin, A. N., & Paget, S. A. (1998) · Cited by 19
Anticonvulsant therapy and cortisol elimination.
Evans, P., Walker, R. F., Peters, J. R., Dyas, J., Riad-Fahmy, D., Jp, T., Rimmer, E., Tsanaclis, L., & Scanlon, M. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb05042.x · Cited by 14
Hatz, H. J., & Helmke, K. (1992) · PubMed · Cited by 13
The dexamethason provocative test: a predictive tool for glaucoma?
Klemetti, A. (1990) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1990.tb01645.x · Cited by 11
Prednisolone enhances β-cell function independently of ambient glycemic levels in type II diabetes
Hosker, J. P., Burnett, M. A., Matthews, D. R., & Turner, R. C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90268-s · Cited by 8
Interpretation of trial methodology not always easy: Comment on the editorial by Landewé
Jacobs, J. W. G., & Bijlsma, J. W. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11265 · Cited by 3
Self-citationRheumatic Disorders and Glucocorticoid-Induced Osteoporosis
Dequeker, J., Westhovens, R., & Luyten, F. P. (2002) · KARGER eBooks · doi:10.1159/000061077 · Cited by 2
Infectious Complications of Corticosteroid Therapy
Simonsen, K. A., & Davies, H. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00108-0 · Cited by 2
Cited by
Smolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Self-citationPeters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Long-term side effects of glucocorticoids
Oray, M., Abu Samra, K., Ebrahimiadib, N., Meese, H., & Foster, C. S. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1140743 · Cited by 869
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Metadata
- Authors
- Da Silva, J. A. P., Jacobs, J. W. G., Kirwan, J. R., Boers, M., Saag, K. G., Inês, L. B. S., de Koning, E. J. P., Buttgereit, F., Cutolo, M., Capell, H., Rau, R., & Bijlsma, J. W. J.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 65
- Issue
- 3
- Pages
- 285-293
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2154341553
- Cited by
- 522
- References
- 145
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.